With approximately 101 million individuals living with diabetes, increasing access to insulin and advanced treatments is ...

Jacqueline Fernandez greets the paps with a smile and wave. Sunny Leone stuns in a green saree, while Rakul Preet Singh keeps it casual at the airport. Tilotamma is spotted in the city. Watch the ...

Divya Dutta, Kubbra Sait, and Ritika Khatnani recently came together to share their favorite memories and engage in fun games. The trio delighted fans with their candid conversations and playful ...

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as it would be easier to manufacture and distribute globally.

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 25 trades. If we consider the specifics of ...

Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitches. The Indianapolis pharma has established an online portal to accept ...

Among the notable guests were Karan Johar and Nora Fatehi. On Tuesday (March 4), YouTuber Lilly Singh posted a carousel of pictures from the bash on Instagram. It was the opening frame that caught ...

Apple's and Eli Lilly's plans to expand manufacturing and development in the U.S. Earning updates from Home Depot and Cava. Jason dives deeper into Axon's earnings with Axon President Josh Isner ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self Pay Journey Program. The company said ...